Why doesn't Hong Qian Pharmaceutical's share price rise?

It is not COVID-19 medicine, nor is it a Chinese medicine or hepatitis medicine developed and produced by Hong Qian Pharmaceutical. Changzhou Hongqian Biochemical Pharmaceutical Co., Ltd. was established by Changzhou Hongqian Biochemical Pharmaceutical Co., Ltd. according to law. The stock price of Hong Qian Pharmaceutical Co., Ltd. did not rise because it was not studying COVID-19 medicine or traditional Chinese medicine, but hepatitis drugs developed and produced by Hong Qian Pharmaceutical Co., Ltd.. Changzhou Hongqian Biochemical Pharmaceutical Co., Ltd. is mainly engaged in R&D, production and sales in biochemical drugs. At present, it mainly produces polysaccharide and enzyme biochemical drugs. * * * has 39 drug production approval numbers, covering raw materials and tablets, injections, capsules and other dosage forms.